Cortechs.ai predates the current wave of AI-diagnostics startups by two decades, having built its NeuroQuant platform to five FDA clearances and deployment across 1,400+ hospitals well before "foundation model" branding became common. Its position is closer to an established infrastructure vendor for quantitative radiology than an emerging entrant, competing on integration reach (a recent Siemens Healthineers distribution partnership) rather than novel technology claims.